Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Kenneth E. Pengel"'
Autor:
Mette S. van Ramshorst, Suzana C. Teixeira, Bas B. Koolen, Kenneth E. Pengel, Kenneth G. Gilhuijs, Jelle Wesseling, Sjoerd Rodenhuis, Renato A. Valdés Olmos, Emiel J. Rutgers, Wouter V. Vogel, Gabe S. Sonke, Marie-Jeanne T. Vrancken Peeters
Publikováno v:
Cancer Imaging, Vol 17, Iss 1, Pp 1-8 (2017)
Abstract Background 18F-FDG PET/CT can monitor metabolic activity in early breast cancer during neoadjuvant systemic therapy (NST), but it is unknown if the metabolic breast and axillary response differ. We evaluated the correlation between metabolic
Externí odkaz:
https://doaj.org/article/829353bcba674cc7be37d6a13918883f
Autor:
Alexander M Th Schmitz, Suzana C Teixeira, Kenneth E Pengel, Claudette E Loo, Wouter V Vogel, Jelle Wesseling, Emiel J Th Rutgers, Renato A Valdés Olmos, Gabe S Sonke, Sjoerd Rodenhuis, Marie Jeanne T F D Vrancken Peeters, Kenneth G A Gilhuijs
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0176782 (2017)
To explore guidelines on the use of MRI and PET/CT monitoring primary tumor response to neoadjuvant chemotherapy (NAC), taking breast cancer subtype into account.In this prospective cohort study, 188 women were included with stages II and III breast
Externí odkaz:
https://doaj.org/article/9e39aff0e90642dba89900deba43eecc
Autor:
Claudette E. Loo, M.T.F.D. Vrancken Peeters, M.E.M. van der Noordaa, E.J.Th. Rutgers, E. van Werkhoven, Emma J. Groen, Wouter V. Vogel, Kenneth E. Pengel
Publikováno v:
European Journal of Surgical Oncology (EJSO). 41:553-558
Background Radioactive Seed Localization with a radioactive iodine-125 seed (RSL) and Radioguided Occult Lesion Localization with 99mTechnetium colloid (ROLL) are both attractive alternatives to wire localization for guiding breast conserving surgery
Autor:
Gabe S. Sonke, Kenneth E. Pengel, Emiel J. Th. Rutgers, Claudette E. Loo, Sjoerd Rodenhuis, Alexander M. Th. Schmitz, Kenneth G. A. Gilhuijs, Wouter V. Vogel, Jelle Wesseling, Renato A. Valdés Olmos, Suzana C Teixeira, Marie Jeanne T.F.D. Vrancken Peeters
Publikováno v:
PLoS ONE, 12(5). Public Library of Science
PLoS ONE, Vol 12, Iss 5, p e0176782 (2017)
PLoS ONE
PLoS ONE [E], 12(5). Public Library of Science
PLoS ONE, Vol 12, Iss 5, p e0176782 (2017)
PLoS ONE
PLoS ONE [E], 12(5). Public Library of Science
Purpose To explore guidelines on the use of MRI and PET/CT monitoring primary tumor response to neoadjuvant chemotherapy (NAC), taking breast cancer subtype into account. Materials and methods In this prospective cohort study, 188 women were included
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::912a92a4bb433ba2b6b9c99dfc0a2000
https://doi.org/10.1371/journal.pone.0176782
https://doi.org/10.1371/journal.pone.0176782
Autor:
Suzana C Teixeira, Bas B. Koolen, Jelle Wesseling, Marie-Jeanne T. F. D. Vrancken Peeters, Emiel J. Th. Rutgers, Gabe S. Sonke, Sjoerd Rodenhuis, Renato A. Valdés Olmos, Mette S. van Ramshorst, Kenneth E. Pengel, Kenneth G. A. Gilhuijs, Wouter V. Vogel
Publikováno v:
Cancer Imaging, Vol 17, Iss 1, Pp 1-8 (2017)
Cancer imaging, 17(1). e-med
Cancer Imaging, 17(1). e-med
Cancer Imaging
Cancer imaging, 17(1). e-med
Cancer Imaging, 17(1). e-med
Cancer Imaging
Background 18F-FDG PET/CT can monitor metabolic activity in early breast cancer during neoadjuvant systemic therapy (NST), but it is unknown if the metabolic breast and axillary response differ. We evaluated the correlation between metabolic breast a
Autor:
Kenneth E. Pengel, Sjoerd Rodenhuis, Jelle Wesseling, Kenneth G. A. Gilhuijs, Wouter V. Vogel, Claudette E. Loo, Emiel J. Th. Rutgers, Marie Jeanne T.F.D. Vrancken Peeters, Bas B. Koolen, Esther H. Lips, Renato A. Valdés Olmos
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 41:1515-1524
Purpose To explore the potential complementary value of PET/CT and dynamic contrast-enhanced MRI in predicting pathological response to neoadjuvant chemotherapy (NAC) of breast cancer and the dependency on breast cancer subtype.
Autor:
Kenneth E. Pengel, Claudette E. Loo, Jelle Wesseling, Kenneth G. A. Gilhuijs, Ruud M. Pijnappel, Emiel J. Th. Rutgers
Publikováno v:
European journal of radiology, 83(2), 273-278. Elsevier Ireland Ltd
To determine when preoperative breast MRI will not be more informative than available breast imaging and can be omitted in patients eligible for breast conserving therapy (BCT). We performed an MRI in 685 consecutive patients with 692 invasive breast
Autor:
Marie-Jeanne T. F. D. Vrancken Peeters, Lisanne S. Rigter, Sjoerd Rodenhuis, Karolina Sikorska, Kenneth G. A. Gilhuijs, Kenneth E. Pengel, Claudette E. Loo, Jelle Wesseling
Publikováno v:
Breast Cancer Research : BCR
Breast cancer research, 18(1). BioMed Central
Breast Cancer Research, 18(1). BioMed Central
Breast cancer research, 18(1). BioMed Central
Breast Cancer Research, 18(1). BioMed Central
BACKGROUND: Pathological complete remission (pCR) of estrogen receptor (ER)-positive/human epidermal growth factor receptor 2 (HER2)-negative breast cancer is rarely achieved after neoadjuvant chemotherapy (NAC). In addition, the prognostic value of
Autor:
Olmos Ra Valdés, Peeters M-J Vrancken, Bas B. Koolen, Jelle Wesseling, K.G.A. (Kenneth) Gilhuijs, Ce Loo, Wouter V. Vogel, Kenneth E. Pengel
Publikováno v:
Cancer Research. 71:P3-14
Background and aim: Contrast-enhanced breast magnetic resonance imaging (MRI) is commonly used for the evaluation of the therapeutic effect of neoadjuvant chemotherapy (NAC). A recent study demonstrated the relevance of breast cancer subtype with reg
Autor:
A. Paape, K.G.A. (Kenneth) Gilhuijs, Kenneth E. Pengel, EEJTh Rutgers, I D Dmitriev, Jelle Wesseling, Ce Loo
Publikováno v:
Cancer Research. 71:P2-08
Background: Typical guidelines for adjuvant systemic drug therapy require assessment of lymph node status, tumor extent and grade. Increasing interest exists, however, for preoperative therapy (neoadjuvant drug therapy and preoperative partial breast